Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
· 7/22/2026, 2:16:14 PM· 2 min read
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
Read original story →Related stories
business
IndusInd bank’s Q1FY27 PAT up 47% on lower provisions
business
Net FDI turned negative again in May 2026 with outflows exceeding inflows by $74 million
business
I travel four hours on a bus per day - the bus fare cap will save me £500 a year
business